Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Ranibizumab therapy for neovascular age-related macular degeneration.

× No keyword cloud information.

41 in total

Review 1. Diabetic retinopathy is a neurodegenerative disorder.

Authors: Stephanie K Lynch; Michael D Abràmoff
Journal: Vision Res Date: 2017-04-28 Impact factor: 1.886

2. Six-year outcomes in neovascular age-related macular degeneration with ranibizumab.

Authors: Julie Jacob; Heidi Brié; Anita Leys; Laurent Levecq; Filip Mergaerts; Kris Denhaerynck; Stefaan Vancayzeele; Eline Van Craeyveld; Ivo Abraham; Karen MacDonald
Journal: Int J Ophthalmol Date: 2017-01-18 Impact factor: 1.779

3. Synthesis and Biological Evaluation of Novel Homoisoflavonoids for Retinal Neovascularization.

Authors: Halesha D Basavarajappa; Bit Lee; Seung-Yong Seo; Timothy W Corson; Hyungjun Lee; Rania S Sulaiman; Hongchan An; Carlos Magaña; Mehdi Shadmand; Alexandra Vayl; Gangaraju Rajashekhar; Eun-Yeong Kim; Young-Ger Suh; Kiho Lee
Journal: J Med Chem Date: 2015-06-16 Impact factor: 7.446

4. [Therapy of stage III retinal angiomatous proliferation. Intravitreal ranibizumab injections].

Authors: M Maier; C Perz; J Bockmaier; N Feucht; C P Lohmann
Journal: Ophthalmologe Date: 2013-12 Impact factor: 1.059

Review 5. Let There Be Light: Gene and Cell Therapy for Blindness.

Authors: Deniz Dalkara; Olivier Goureau; Katia Marazova; José-Alain Sahel
Journal: Hum Gene Ther Date: 2016-02 Impact factor: 5.695

6. Bufadienolides and anti-angiogenic homoisoflavonoids from Rhodocodon cryptopodus, Rhodocodon rotundus and Rhodocodon cyathiformis.

Authors: Hannah Whitmore; Kamakshi Sishtla; Walter Knirsch; Jacky L Andriantiana; Sianne Schwikkard; Eduard Mas-Claret; Sarah M Nassief; Sani M Isyaka; Timothy W Corson; Dulcie A Mulholland
Journal: Fitoterapia Date: 2020-01-09 Impact factor: 2.882

7. Combination of ranibizumab with photodynamic therapy vs ranibizumab monotherapy in the treatment of age-related macular degeneration: a systematic review and meta-analysis of randomized controlled trials.

Authors: Jun-Kang Si; Kai Tang; Hong-Sheng Bi; Da-Dong Guo; Jun-Guo Guo; Yu-Xiang Du; Yan Cui; Xue-Mei Pan; Ying Wen; Xing-Rong Wang
Journal: Int J Ophthalmol Date: 2014-06-18 Impact factor: 1.779

Ranibizumab therapy for neovascular age-related macular degeneration.